Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

EXPLAINER: Is it time to get a COVID-19 booster? Which one?

10/22/2021 | 12:18pm EST

Millions more Americans just became eligible for COVID-19 boosters, but figuring out who's eligible and when can be confusing. And adding to the challenge is that this time around, people can choose a different brand of vaccine for that extra dose.

A number of factors, including the vaccine you started with and when your last dose was, help determine when you qualify. Just like the initial shots, boosters are free and will be available at pharmacies, doctors' offices and clinics.

Here are some things to know:

WHY ARE BOOSTERS NEEDED?

People who are fully vaccinated are still strongly protected against hospitalization and death from COVID-19. But immunity against infection can wane over time, and the extra-contagious delta variant is spreading widely. U.S. health authorities want to shore up protection in at-risk people who were vaccinated months ago, though they emphasize that the priority remains getting the unvaccinated their first shots.

ARE BOOSTERS AVAILABLE FOR ALL THREE VACCINES AUTHORIZED IN THE U.S.?

Yes, Pfizer boosters began last month, and this week the government cleared extra doses of the Moderna and Johnson & Johnson vaccines too. More than 120 million Americans will become eligible for a booster in the coming months, or about 2 out of every 3 vaccinated adults, officials say. But who’s eligible — and when — differs depending on which vaccine you got first.

CAN I GET A BOOSTER NOW?

If you got Pfizer or Moderna shots first, you’re eligible if your last dose was at least six months ago and you’re 65 or older, or are a younger adult who has health problems or a job or living conditions that put you at higher risk of severe illness or exposure to the coronavirus. Health care workers, for example, are included because they are regularly exposed to the virus and can’t come to work with even the mildest of infections.

WHAT IF I GOT THE J&J SHOT?

Anyone who got a J&J shot at least two months ago is eligible, regardless of age or other factors.

WHY ARE THERE DIFFERENT RECOMMENDATIONS FOR THE DIFFERENT VACCINES?

A single shot of the J&J vaccine is less effective than two doses of the Moderna or Pfizer formulas, and health authorities decided it was important for the J&J recipients to achieve a similar level of protection. As for the timing, J&J simply tested more people with a two-month booster than one at six months. For recipients of Moderna or Pfizer vaccinations, there's no clear data that everybody needs another dose, but immunity against infection in at least some people appeared to wane around six months.

WHAT IF I DON'T WANT TO WAIT SIX MONTHS?

Experts agree that getting a booster too soon can reduce the benefit. Timing matters because the immune system gradually builds layers of defenses over months, and letting that response mature improves the chances another, later dose will provide even stronger protection.

WHAT DOES ‘MIXING AND MATCHING’ BOOSTER DOSES MEAN?

It means a booster of a different brand from your original vaccination. That gives flexibility in situations such as nursing homes where only one type of booster might be brought in. It also gives people at risk of a rare side effect linked to one kind of vaccine the option of switching to a different shot.

SHOULD I SEEK OUT A DIFFERENT VACCINE?

The Centers for Disease Control and Prevention and Food and Drug Administration didn't recommend that people switch but left open the option. Preliminary results of a government study found an extra dose of any vaccine triggered a boost of virus-fighting antibodies regardless of what shots people got to begin with. For people who originally got a J&J vaccination, the Moderna and Pfizer shots appeared to offer a stronger boost. But researchers cautioned the study was too small to say one combination is better than another.

DO I NEED A BOOSTER TO STILL BE CONSIDERED FULLY VACCINATED?

No, the CDC says people still are considered fully vaccinated starting two weeks after the second dose of the Moderna or Pfizer vaccines, or the single-dose J&J shot. CDC Director Dr. Rochelle Walensky says the definition of fully vaccinated is not being changed for now because not everyone is eligible for boosters at this point.

WILL THIS BE MY LAST BOOSTER?

Nobody knows. Some scientists think eventually people may get regular COVID-19 shots like annual flu vaccinations. But researchers will need to study how long protection from the current boosters lasts.

The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
MODERNA, INC. 20.57% 329.63 Delayed Quote.215.53%
PFIZER, INC. 6.11% 54 Delayed Quote.46.70%
All news about PFIZER, INC.
07:00aHow worried should we be about the Omicron variant?
RE
01:10aPARENTING IN A PANDEMIC : To Vaccinate Or Not To Vaccinate?
AQ
11/26ADRs Close Lower; BioNTech Rises, Carnival Drops
DJ
11/26US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New COVID-19 Stra..
MT
11/26CLOSE UPDATE : US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New C..
MT
11/26FTSE 100 Closes Friday Down as Latest Coronavirus Variant Sparks Sell-off
DJ
11/26Covid-19 Vaccine Maker Stocks Higher Amid Variant Concerns
DJ
11/26New purchase in the MarketScreener USA Portfolio
11/26FDA Places Clinical Hold on Phase 3 Study for Ocugen COVID-19 Vaccine Covaxin
MT
11/26Pfizer Up Over 6%, on Track for Record High Close -- Data Talk
DJ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 529 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 827 M - -
P/E ratio 2021 13,9x
Yield 2021 2,92%
Capitalization 303 B 303 B -
EV / Sales 2021 4,06x
EV / Sales 2022 3,97x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 54,00 $
Average target price 48,53 $
Spread / Average Target -10,1%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.46.70%303 095
JOHNSON & JOHNSON1.82%419 109
ROCHE HOLDING AG16.05%336 162
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049
ABBVIE INC.8.74%205 976